Skip to Main content Skip to Navigation
Journal articles

Contribution of Nanotechnologies to Vaccine Development and Drug Delivery against Respiratory Viruses

Abstract : According to the Center for Disease Control and Prevention (CDC), the coronavirus disease 2019, a respiratory viral illness linked to significant morbidity, mortality, production loss, and severe economic depression, was the third-largest cause of death in 2020. Respiratory viruses such as influenza, respiratory syncytial virus, SARS-CoV-2, and adenovirus, are among the most common causes of respiratory illness in humans, spreading as pandemics or epidemics throughout all continents. Nanotechnologies are particles in the nanometer range made from various compositions. They can be lipid-based, polymer-based, protein-based, or inorganic in nature, but they are all bioinspired and virus-like. In this review, we aimed to present a short review of the different nanoparticles currently studied, in particular those which led to publications in the field of respiratory viruses. We evaluated those which could be beneficial for respiratory disease-based viruses; those which already have contributed, such as lipid nanoparticles in the context of COVID-19; and those which will contribute in the future either as vaccines or antiviral drug delivery systems. We present a short assessment based on a critical selection of evidence indicating nanotechnology’s promise in the prevention and treatment of respiratory infections.
Document type :
Journal articles
Complete list of metadata

https://hal-cnrs.archives-ouvertes.fr/hal-03423555
Contributor : Colette Orange Connect in order to contact the contributor
Submitted on : Wednesday, November 10, 2021 - 10:52:40 AM
Last modification on : Friday, November 12, 2021 - 3:12:07 AM

File

mignet-hindawi.pdf
Publisher files allowed on an open archive

Identifiers

Collections

Citation

Mahdi Ftouh, Nesrine Kalboussi, Nabil Abid, Souad Sfar, Nathalie Mignet, et al.. Contribution of Nanotechnologies to Vaccine Development and Drug Delivery against Respiratory Viruses. PPAR Research, Hindawi Publishing Corporation, 2021, 2021, pp.1-28. ⟨10.1155/2021/6741290⟩. ⟨hal-03423555⟩

Share

Metrics

Record views

11

Files downloads

14